• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Objectives To determine the quantitative efficacy of different classes of blood pressure
lowering drugs in preventing coronary heart disease (CHD) and stroke, and who should …

Wytyczne dotyczące nadciśnienia tętniczego opublikowane w 2013 r. przez Europejskie
Towarzystwo Nadciśnienia Tętniczego (ESH) i Europejskie Towarzystwo Kardiologiczne …

On behalf of the Brazilian Society of Cardiology, Brazilian Society of Hypertension and
Brazilian Society of Nephrology, I present to you the 7th Brazilian Guideline of Arterial …

Recommendations about therapy for hypertension are here preceded by some
considerations on the strength of available evidence on the benefits associated with …

†European guidelines on cardiovascular disease prevention in clinical practice: executive
summary | European Heart Journal | Oxford Academic Skip to Main Content Advertisement …

Context β-Blockers remain the standard of care after a myocardial infarction (MI). However,
the benefit of β-blocker use in patients with coronary artery disease (CAD) but no history of …

Background Beta‐blockers refer to a mixed group of drugs with diverse pharmacodynamic
and pharmacokinetic properties. They have shown long‐term beneficial effects on mortality …

Journal of Hypertension Log in or Register Subscribe to journalSubscribe Get new issue
alertsGet alerts Submit your manuscript Secondary Logo Journal Logo Advanced Search Toggle …

The goal of antihypertensive therapy is to abolish the risks associated with blood pressure
(BP) elevation without adversely affecting quality of life. Drug selection is based on efficacy …